Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a website/platform release rather than a change to the study information.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3 tag.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or user-facing content.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.4.2 was added and the government funding notice along with Revision: v3.4.1 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedAdded a site-wide notice about the government funding lapse and NIH Clinical Center operating status with links for more information. Updated the page footer from Revision: v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.